Maternal physiology Flashcards

1
Q

Changes to the uterus in pregnancy

A
  1. Hyperplasia - increased weight and height
  2. Uterine ligaments stretch + hypertrophy
  3. Right dextro-rotation
  4. Lower segment
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Changes to the cervix, vulva and vagina during pregnancy

A
Cervix:
¥	Edematous congestion
¥	Eversion of columnar cells
¥	Increased secretion of cervical glands
¥	Mucous plug (operculum)

Vulva - increased vascularity and varicosities

Vagina - increased vascularity and distension at birth

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Breast changes in pregnancy

A

¥ Increased size and vascularity – warm, tense and tender
¥ Increased pigmentation of nipple and areola
¥ Secondary areolar appear - light pigmentation around primary areolar
¥ Montgomery tubercles appear on areolar – dilated sebaceous glands
¥ Colostrum expressed from as early as 16 weeks

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Pituitary and endocrine changes in pregnancy

A

PITUITARY
¥ Anterior pituitary increase in size and activity
¥ Posterior pituitary releases oxytocin at onset of labour and during lactation

THYROID
¥ Increase in size and activity
¥ TBG levels double
¥ Increase in total T3 and total T4 (not free T3/4)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Progesterone changes in pregnancy

A

¥ Produced by corpus luteum then placenta

¥ Levels rise steadily during pregnancy until output reaches 250mg/day

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Progesterone actions in pregnancy

A

o Relaxation
o Nausea, colon activity reduced, constipation
o Reduced bladder and uteric tone
o Diastolic BP reduced
o Venous dilation and raised temperature
o Anti inflammatory

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Oestrogen source, levels and actions in pregnancy

A

Source
¥ Ovary early, placental and fetal adrenals later
¥ Oestrone and oestradiol produced by placenta
¥ Oestriol produced by placenta and fetal adrenals
Levels
¥ Reaches a maximum of 30-40mg/day
¥ Levels increase up to term
Actions
¥ Induces growth of uterus
¥ Responsible for development of breasts (progesterone too)
¥ Alters chemical constitution of connective tissues
¥ Water retention
¥ Reduced sodium excretion

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Urinary changes in renin during pregnancy

A
INCREASED RENIN 
¥	Stimulated by progesterone 
¥	Made in placenta 
¥	Net excretion of Na+
¥	Excretion of K+
¥	Water retention 6-8L
¥	Reduced osmolarity
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Implications of urinary changes during pregnancy

A

¥ Frequency a symptom of pregnancy

¥ Increased UTI (stasis/reflux) – easy to miss

¥ Increased pyelonephritis

¥ Increase in challenges interpreting renal imaging during pregnancy

o Right physiologic hydronephrosis

¥ Increased oedema

o Low oncotic pressure
o Fluid retention

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Neural tube defects incidence and types

A

1/1000 births

  • anencephaly
  • spinabifida
  • encephalocele
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Neural tube development

A

¥ The closure of the neural tube begins in the cervical area (in the middle of the embryo) and spreads from there in the cranial and caudal directions.
¥ Cranial end closes by day 24 and the caudal end by day 26.
¥ If the posterior neuropore does not close, spina bifida occurs.
¥ If the closure of the anterior neuropore fails to take place, anencephaly results.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Risk factors for neural tube defects

A

2-5% recurrence in subsequent pregnancies

Genetic influences
o Known genetic syndromes (egtrisomy 18)
o Familial clustering

Multiple pregnancies

Environmental agents
- Hyperthermia (saunas, maternal pyrexia)

Nutritional deficiencies

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Importance of folate in pregnancy

A
  • Folate deficiency: accumulation of homocysteine – associated with cardiovascular disease risk
  • Several gene polymorphisms affect folate metabolism
  • These are associated with reduced folate absorption and therefore increased folate needs
  • MTHFR (methylene-tetrahydrofolate reductase) gene mutation: affects 8-35% population depending upon ethnicity
  • Reduced folate carrier (RFC1) gene
  • In the absence of a folate-sufficient diet these mutations are associated with an increased risk of NTDs and conotruncal cardiac anomalies
  • Reduces the prevalence of NTD
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Recommended folate intake during pregnancy

A
  • Women with no risk factors for NTD: 400 mcg folic acid preconception until 12 weeks gestation
  • Women with risk factors (prior NTD, diabetes, antiepileptic medications): 5 mg folic acid
  • 5-methyl-tetrahydrofolate (5-MTHF) has been proposed as an alternative to folic acid supplementation.

• 2009: mandatory folic acid fortification in Australia
o 200-300mcg/100gflour

o NTDs predicted to fall 40-70%

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Cause of trisomy 21

A

95% due to non-disjunction

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Techniques for diagnosing trisomy 21

A

o Prenatal diagnosis based on maternal age
(amniocentesis/CVS)

o Combined First Trimester Screening (80-90% detection rate)

o Second Trimester Screening (60-70% detection rate)

o Non-invasive Prenatal Testing (99.5% detection rate)

17
Q

Cardiovascular defects

A

Hypoplastic left heart syndrome
Tetralogy of fallot
Transposition of great arteries

18
Q

Medications and birth defects - category A

A

Drugs taken by large number of pregnant/women of childbearing age
- thyroxine, folic acid

19
Q

Medications and birth defects - category B1/2/3

A

1) Drugs taken by limited number of pregnant women
No increase in harmful effects/malformations
- azithromycin, cetaxime

2) Drugs taken by limited number of pregnant women, studies in animals are lacking but no evidence of harm
- vaccines

3)Drugs taken by limited number of pregnant women
Evidence of increased risk in animals, unsure in humans

20
Q

Medications and birth defects - category C

A

• Drugs which, owing to their pharmacological effects, have caused or may be suspected of causing, harmful effects on the human fetus or neonate without causing malformations. These effects may be reversible.

Example: naproxen, nifedipine, oxprenolol, metformin

21
Q

Medications and birth defects - category D

A
  • Drugs which have caused, are suspected to have caused or may be expected to cause, an increased incidence of human fetal malformations or irreversible damage. These drugs may also have adverse pharmacological effects.
  • Example: phenytoin, ramipril
22
Q

Category X

A
  • Drugs which have such a high risk of causing permanent damage to the fetus that they should not be used in pregnancy or when there is a possibility of pregnancy
  • Example: methotrexate, retinoic acid, thalidomide,
23
Q

Benefits of breastfeeding to the mother

A
• Recoveryfromchildbirth •  Body weight loss 
• Suppression of maternal
fertility
• Cholesterol clearance 
• Diabetics – glucose control 
• Breast & ovarian cancer
less
• Self esteem
24
Q

Benefits of breast feeding to the child

A
  • ‘Gold Standard’ infant food
  • Facilitatesgrowthand development
  • Protects against illness
25
Q

Functions of breast milk in the CNS and immune system

A

CNS
• HigherDHAinparietalcortexofbrainsof breastfed infants
• Someevidenceofimprovedvisualacuity and cognitive development, particularly for preterm infants

IMMUNE SYSTEM
Immunoglobulins – sIgA Lactoferrin
Lysozyme
Lipids
Oligosaccharides Cytokines
Cells
26
Q

5 pathways of milk synthesis and secretion

A
  1. membrane pathway
  2. transcellular pathway
  3. fat globule
  4. golgi vesicle
  5. paracellular pathway
27
Q

Which deficiency is not related to maternal intake in breastfed infants?

A

Vit K

28
Q

Which minerals and vitamins have a recognisable nutritional deficiency in breastfed infants

A
Iron - related to mother's intake
Iodine
Vit A,B6,B12,C,D,E,K
Thiamin
Biotin
Folate
29
Q

What does initiation of lactation require?

A
  1. withdrawal of progesterone

2. Presence of prolactin, insulin and corticosteroids

30
Q

Milk ejection

A
  • Suckling stimulates the supraoptic and paraventricular nuclei in the hypothalamus
  • Oxytocin released from the posterior pituitary into the bloodstream
  • Critical for successful lactation
  • Can be conditioned
  • Can be inhibited by stress
31
Q

Inhibition of milk ejection

A
  • Impairedoxytocinrelease–opiates, alcohol
  • Impairedinnervation–reduction mammoplasty
  • Stress–adrenalinecausing vasoconstriction
  • ?engorgement–ratscollapsingof capillaries
32
Q

Secondary breastfeeding problems

A
  • delayed breastfeeding
  • inadequate prolactin
  • inadequate infant suction
  • nipple pain
  • blocked duct
  • mastitis
33
Q

Potential causes of sore nipples

A
  • Baby positioning
  • Strong vacuum
  • Tongue tie
  • Staph. Aureus
  • Candida albicans
34
Q

Hormonal initiation of labour

A

Ant. Pit: releases ACTH
Adrenal glands: release glucocorticoids and androgens
Placenta: reduces progesterone and increases oestrogen
Progesterone: increases uterine sensitivity to stretch
Oestrogen: increases uterine contraction, increases sensitivity to oxytocin and softens cervix

Cervix softening > stretching of cervix + vagina > uterine contractions > labour >